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ABSTRACT 33 
Background: Electronic cigarette regulations included in the Tobacco Products Directive 34 
(TPD), Article 20, implemented in Europe by May 2017, aimed to improve safety for e-35 
cigarette consumers, and prevent uptake among non-smokers, particularly young people. 36 
Before implementation, there were significant concerns from consumers, industry, and some 37 
in the scientific community about the potential negative impact of the TPD on people using e-38 
cigarettes to stay stopped from smoking.  To date, there is limited evidence on how the TPD 39 
has affected consumers. This study aimed to add insight into how consumers perceived and 40 
experienced the regulations. 41 
Methods: Qualitative data, collected between March 2018 and March 2019, relating to 42 
participant views of the TPD were extracted from 160 interviews/extended surveys of e-43 
cigarette consumers as part of a wider study into e-cigarette use trajectories (ECtra study). 44 
Data were thematically analysed. 45 
Results: Awareness of the TPD amongst consumers was not universal. Participants’ smoking 46 
behaviour did not appear to be influenced by the legislation. Participants were reassured by 47 
manufacturing regulations and requirements for ingredients labels. Participants responded 48 
negatively to changes perceived to cause inconvenience and extra plastic waste. The product 49 
restrictions prompted some participants to purchase noncompliant products illegally, 50 
potentially putting their safety at risk.  51 
Conclusions: E-cigarette regulation should focus on ensuring product safety. Raising 52 
awareness of the TPD amongst consumers and smokers could be beneficial.       53 
 54 
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INTRODUCTION  58 
E-cigarettes are now the most popular smoking cessation aid chosen by UK smokers (1) and 59 
have been shown to be an effective aid for smoking cessation (2, 3). However, although they 60 
are recognised as being much less harmful than tobacco smoking (4), the long-term health 61 
effects are not yet known (5) and there is concern, particularly in the US, about the potential 62 
for youth uptake, and subsequent nicotine addiction amongst never smokers (6).  A number 63 
of studies have demonstrated that e-cigarette liquid and aerosol does contain harmful and 64 
potentially harmful compounds (e.g. carbonyl compounds with carcinogenic potential, heavy 65 
metals, respiratory irritants (7, 8); the levels of which can vary depending on the nature of the 66 
device and usage conditions  (9, 10, 11).  Although these levels are typically far lower than 67 
those found in tobacco smoke (7, 11), the effects of repeated inhalation on health are yet to be 68 
quantified.  Encouragingly, studies of respiratory health have demonstrated fewer respiratory 69 
symptoms in exclusive e-cigarette users (vapers) compared with smokers (12) and smokers 70 
with asthma or COPD report symptom improvement when switching to e-cigarettes (13, 14).   71 
Similarly, studies measuring urinary biomarkers of exposure to cancer, cardiovascular and 72 
respiratory disease typically record far lower levels of these markers in e-cigarette users 73 
compared with smokers (15-19). Nevertheless, the absolute risk of long-term e-cigarette use 74 
(vaping) is yet to be determined, and there have been reported outbreaks of adverse reactions 75 
related to the misuse of e- cigarettes; (e.g. by vaping adulterated or unregulated e-liquids) 76 
(20). Ensuring that e-cigarette devices and e-liquids are as safe as they can be, falls partly 77 
under the remit of legislation and regulation.    78 
 79 
Regulation of e-cigarettes varies considerably around the world, from no legalisation in 80 
around half of countries to a complete ban on sales in twenty-nine countries (21).  In the 81 
European Union (EU), the revised Tobacco Products Directive (TPD) was implemented 82 
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between May 2016 and May 2017. The TPD included e-cigarettes (Article 20), introducing 83 
regulations including refill liquid containers limited to a maximum volume of 10ml with no 84 
higher than 20mg/ml nicotine concentration; refillable tanks and cartridges (the reservoir 85 
included in the e-cigarette which holds the e-liquid) were not to exceed a capacity of 2ml; all 86 
vaping products to include a health warning label stating that “this product contains nicotine 87 
which is a highly addictive substance”; and liquid packaging to list ingredients. In addition, 88 
the TPD prohibits specific hazardous ingredients and requires producers to notify their 89 
country’s relevant regulatory authority before launching a product to market (22).  90 
 91 
The TPD regulations were introduced with the intention to increase e-cigarette safety by 92 
setting minimum standards and providing information to consumers to allow them to make 93 
informed choices, whilst also protecting children and deterring never-smokers from trying e-94 
cigarettes by limiting marketing and including nicotine warning labels. The vaping 95 
community and some scientists raised concerns that a reduction in nicotine strength might 96 
stop smokers from quitting using e-cigarettes, or cause users to relapse to smoking, as the 97 
lower strength may not satisfy cravings (23-25). However, cross-sectional survey evidence 98 
suggests that the limits on nicotine strength do not appear to have influenced consumers 99 
previously using non-compliant high strengths to be more susceptible to returning to 100 
smoking, as feared (26). UK policy makers were worried that price increases would drive 101 
consumers to the black market, potentially putting their health at risk (27). It is not clear to 102 
what extent this concern is warranted, but consumers and retailers have found legal methods 103 
to overcome the restrictions resulting from the TPD. For example, some consumers 104 
stockpiled high nicotine concentrations of e-liquid for use in mixing their own liquids (28), 105 
and many retailers embraced product innovation, such as selling ‘nicotine shots’ (29). These 106 
are TDP compliant 10ml bottles containing unflavoured nicotine of the maximum legally 107 
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permitted strength of 20mg/ml; users dilute the nicotine in larger bottles of 0mg/ml liquid, 108 
enabling them to legally possess a large bottle of e-liquid tailored to their desired nicotine 109 
strength.  110 
 111 
Evidence investigating how the TPD is experienced by consumers is limited, but is vital for 112 
policy makers to consider when developing e-cigarette policy. Indeed, the UK Government 113 
has recently made a commitment to review the TPD restrictions relating to nicotine strength 114 
limits, tank restrictions, advertising, and ingredient notifications, in light of the UK’s exit 115 
from the EU (30). This is the first study to our knowledge using in-depth qualitative 116 
exploration of consumers’ views and experiences of the TPD regulation since its 117 
implementation.  118 
 119 
METHODS 120 
The data drawn upon to answer the research question ‘How do vapers perceive  and 121 
experience the EU Tobacco Products Directive (2017) as applied to e-cigarettes (Article 122 
20)?’ are taken from Phase 2 of a wider longitudinal study, the ‘E-Cigarettes Trajectories 123 
Study’ (ECtra), exploring patterns of e-cigarette use in relation to preventing smoking relapse 124 
through longitudinal mixed methods data collection [31, 32]. The study received ethical 125 
approval from the UEA Faculty of Medicine and Health Sciences Research Ethics Committee 126 
(project reference: 2017/18 – 106).   127 
 128 
 129 
Recruitment and sampling 130 
Between March 2018 and March 2019, 184 participants took part in Phase 2 of the study, 12-131 
18 months after they initially participated in Phase 1 of the study (2016- 2017). The 132 
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eligibility criteria included people aged 18 years or above, who had attempted to use an e-133 
cigarette for smoking cessation. Participants were originally recruited into Phase 1 of the 134 
study through word of mouth, local press articles, university bulletins, vape shops, and social 135 
media. The ECtra study was initially designed to be an interview study, but due to over 136 
recruitment, the research team devised an alternative survey version of the interview which 137 
was shared with project enquirers who were unable to participate in an interview, and on 138 
social media.  139 
 140 
Forty interview participants were recruited for Phase 1 and thirty-seven participants were 141 
interviewed for Phase 2 (one participant declined Phase 2 participation due to personal 142 
reasons and two did not respond to contact attempts). With regards to the survey, 371 143 
participants were recruited for Phase 1 and 147 participated in Phase 2 (seventy-seven did not 144 
provide an email address at Phase 1, fifty-seven started the Phase 2 survey but did not 145 
complete, and ninety did not respond to emailed requests to complete the Phase 2 survey).  At 146 
Phase 2, only participants who identified themselves as being resident in the EU were asked 147 
about the TPD; this included all interview participants and 125/147 survey participants. Two 148 
EU based survey participants did not provide an answer to the TPD question resulting in a 149 
final sample of n=160.  150 
 151 
Procedure 152 
The Phase 2 online survey and interview topic guide were developed in consultation with lay 153 
consultants. Both data collection tools asked similar questions. The questions were derived 154 
from findings illuminated from Phase 1 of the ECtra study (29, 31, 33), and related to relapse 155 
pathways (34) and partnership working between healthcare professionals and the vaping 156 
industry (35). In addition, a question about the perceived impact of the TPD was included to 157 
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explore experiences of the legislation which had come into full effect in May 2017, just after 158 
Phase 1 of the study had completed. Only data generated from that one question were 159 
analysed for this paper. Both data collection instruments included the same question phrasing 160 
(Appendix 1). 161 
 162 
Analysis  163 
Participants gave informed consent before taking part in a confidential online survey or 164 
telephone (25)/face-to-face (12) interview. Interviews were recorded, transcribed verbatim, 165 
and anonymised. Surveys were administered via the Qualtrics online survey platform (36) 166 
using a hyperlink and data were downloaded once the survey closed. Participant responses to 167 
the TPD question were extracted from interview transcripts and downloaded survey data, 168 
then were uploaded to NVivo 12 qualitative analysis software (37). The extracts were coded 169 
using a standardised thematic analysis method (38): CA coded data for latent and semantic 170 
content within the interview sample data, with EW coding a subset of approximately 10% of 171 
interview data to check for coding consistency. Codes were iteratively reviewed and sorted 172 
into subthemes and overarching themes by CA in discussion with EW until data analysis 173 
saturation was achieved with no new codes being generated. This coding structure was 174 
applied deductively to coding of the survey sample by CA and EW, allowing for inductive 175 
coding and iterative sorting of themes as needed. Following this, the themes were written up 176 
with illustrative quotes for each identified theme by CA and EW. As is typical in in 177 
qualitative research, this sometimes resulted in the recoding and categorising of the data.  The 178 
final analytical write up was critically reviewed by EW resulting in a comprehensive 179 
interpretation of the data in relation to the research question and the final thematic structure 180 
agreed by CA, EW, and CN.  181 
 182 
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RESULTS 183 
Profile of participant characteristics is reported in Table 1. Just over a quarter of all 184 
participants were female (41, 27.3%), ages ranged from 22 to 79 years (mean 49, SD 12.37), 185 
three participants were from Black, Asian, and minority ethnicities (BAME), and 45.9% (67) 186 
were employed in managerial, professional or technical occupations (39). Most (133, 89.9%) 187 
participants identified as being resident in the UK due to this being where the UK based 188 
research team recruited, and that English language was used. The vast majority of 189 
participants were vaping and abstinent from tobacco (139, 86.9%), 10 participants had 190 
relapsed (4 dual using both tobacco and vaping), and 11 were no longer using either e-191 
cigarettes or tobacco. Of those using e-cigarettes at the time of Phase 2 data collection, the 192 
median length of use was four years (range 1-9) and the vast majority did not plan to quit 193 
using e-cigarettes (124, 86.7%). The survey and interview samples differed mainly on gender 194 
and vaping status.  No participants reported regular use of smokeless ‘heat-not-burn’ tobacco 195 
products. 196 
 197 
 198 
 Interview sample 
n=37 
Survey sample* 
n=123 
Combined int/survey 
sample n=160 
Gender: 
Male 
Female 
 
51.4% (19) 
48.6% (18) 
 
79.6% (90) 
20.4% (23) 
 
72.7% (109) 
27.3% (41) 
Age (n=150): 
  Range (years) 
  Mean (years) 
 
49: 22-71 
42 (SD 14.32) 
 
53: 26-79 
52 (SD 10.71) 
 
57: 22-79 
49 (SD 12.37) 
Ethnicity: 
  White 
  BAME 
 
100% (37) 
 
97.3% (108) 
2.7% (3) 
 
98% (145) 
2% (3) 
Managerial, professional, or technical 
occupation:  
 
37.8% (14) 
 
48.6% (53) 
 
45.9% (67) 
Resident location: 
UK 
Other EU  
 
97.3% (36) 
2.7% (1) 
 
87.4% (97) 
12.6 (14) 
 
 
89.9% (133) 
10.1% (15) 
T2 vaping status: 
Vaping and abstinent from tobacco   
Abstinent from both vaping and tobacco  
 
62.2% (23) 
16.2% (6) 
 
97.3% (116) 
4.1% (5) 
 
86.9% (139) 
6.9% (11) 
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Relapsed to tobacco (dual using) 
Relapsed to tobacco (not vaping) 
5.4% (2) 
16.2% (6) 
1.6% (2) 2.5% (4) 
3.8% (6) 
Approx. years using e-cig at T2 (for vaping 
participants only, n=79) 
   Range 
   Median 
 
 
 
8: 1 -8 
4 
 
 
9: 1-10 
4 
 
 
9: 1-9 
4  
T2 future intentions to 
continue/discontinue vaping (for vaping 
participants only, n-143) 
   No plans to quit vaping 
   Plans to quit vaping  
 
 
96% (24)  
4% (1) 
 
 
87.7% (100) 
15.3% (18) 
 
 
86.7% (124) 
13.3% (19) 
   
*Only included participants identifying as resident in EU who answered the TPD question 199 
Table 1: Profile of participant characteristics (n=160) 200 
 201 
Overarching themes relating to participants’ perceptions of the TPD regulation were 202 
identified (Table 2) and are discussed in turn using illustrative quotes from both survey and 203 
interview data. Numbers of participants discussing each individual theme are not provided in 204 
line with common qualitative practices (40), as the aim of the analysis was to identify 205 
possible perspectives and experiences of the TPD, rather than infer prevalence of experience.  206 
Forty-six (28.7%) participants reported no awareness of the TPD or any personal behavioural 207 
reactions/ negative impacts. In these instances, participants’ opinions about the TPD 208 
regulations were elicited. Within the sample, males were four times more likely to report a 209 
behavioural reaction or negative impact compared to women (X2 (2, N=150)=13.04, p<.01, 210 
OR=3.93).  211 
 212 
THEME EXAMPLE QUOTATION 
Perceived Impacts – how consumers perceive 
the TPD has affected them 
 
Low awareness and no perceived impact “It has not affected me.” (SurveyNo.48) 
Reassurance about e-liquid ingredients – 
makes vaping feel safer 
“I think the TPD has been good at cleaning up the market 
from foreign imports which could contain poor 
ingredients.” (SurveyNo.42) 
 
Limits consumer choice - makes vaping 
more expensive, less accessibility to 
effective products 
“Strength restrictions mean many early stage vapers fail 
because they can't get the nicotine level needed and those 
who do stay on are using more eliquid than would 
otherwise be needed. This means more vapour is 
produced leading to more complaints.” (SurveyNo.60) 
Inconveniences consumer – makes 
vaping more complicated through 
“Tank Capacity (2ml) - To me this seems pointless and 
unnecessary.” (SurveyNo.22) 
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increased refilling and bottle 
purchasing/carrying 
Increases plastic waste “People have to fill up tanks more often, carry extra 
bottles of juice and the 10ml bottles greatly increased 
plastic waste.” (SurveyNo.26) 
Behavioural Reactions – how consumers 
perceive they have responded to the changes 
 
Already using compliant products – no 
reaction 
 
“The e-liquid I’ve been buying has always only come in 
10 mils so I guess [the TPD] hasn’t really crossed my 
consciousness at all.” (InterviewNo.18) 
Stocking up on non-compliant products 
pre-TPD - including large quantities of 
nicotine 
“I home mix and stocked up on 72mg before the 
deadline.” (SurveyNo.101) 
Market reactions such as nicotine shots “10 mil bottles are ridiculous, suppliers get round this by 
doing nicotine shots. This needs to change fast.” 
(SurveyNo.25) 
Buying from black market/abroad– 
concerns about safety 
“I have actively defied the TPD, importing directly from 
china.” (SurveyNo.33) 
Future Reflections – what consumers believe 
regulation should focus on 
 
To avoid confusing switchers, removal 
of nicotine warning labels on vaping 
products not containing nicotine should 
be considered  
“Nicotine labels = ridiculous, laughable idiocy.” 
(SurveyNo.69) 
To reduce possible health risks, further 
regulation of e-liquid ingredients/product 
safety desired 
“Perhaps there’s potential for further regulation because 
obviously there’s a myriad of people selling vaporising 
products now.” (InterviewNo.1)  
Table 2: Summary of themes identified and example quotations relating to participants’ views and 213 
experiences of the Tobacco Products Directive regulatory changes  214 
 215 
Perceived Impacts 216 
Irrespective of whether or not participants were aware of the legislation, most participants 217 
supported some form of regulation designed to promote consumer safety: 218 
 219 
“You do need regulation in things like this, because it is going into somebody’s body. It’s a 220 
risk with operational, in the fact that it’s got batteries in it, you definitely need regulation.” 221 
(InterviewNo.31) 222 
 223 
The most popular change initiated by the TPD was the requirement for ingredients lists on e-224 
liquid bottles. This reassured most participants to some extent, allowing them to know what 225 
they were inhaling and to exert choice over which ingredients they were consuming:  226 
 227 
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 “You would expect to find the ingredients on food that you buy, wouldn’t you? So why 228 
shouldn’t they be on the vaping liquids? So yeah, I think they should have them, and I 229 
suppose as well, that can help you avoid certain things.”(InterviewNo.30) 230 
 231 
Some participants were using compliant products prior to the TPD implementation and, 232 
therefore, did not feel that their purchasing was negatively restricted: 233 
 234 
“Not worried about strength as I use a fairly low strength anyway.”(SurveyNo.126) 235 
 236 
Although a small number of participants had noticed a decrease in price due to competition 237 
between shops, many participants had noted an increase in price:   238 
 239 
 “The legislation has made it difficult for me to cost-effectively buy consumables for vaping 240 
(coils, e-liquid). In a large number of cases, hardware has also increased in price.” 241 
(SurveyNo.102) 242 
 243 
The restriction on e-liquid strength to 20mg/ml was considered too low by many participants.  244 
Although no participants mentioned lapsing themselves as a result of the changes, several 245 
commented that it may prevent smokers from converting to vaping as they needed over 246 
20mg/ml of nicotine when they initially stopped smoking: 247 
 248 
 “20mg is useless for heavy smokers wanting to switch, I needed 36mg to start 5 years ago, 249 
so more will fail and go back to smoking”(SurveyNo.41) 250 
 251 
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Some participants commented that products they normally used were no longer sold as they 252 
did not comply with the new regulations, resulting in having to buy new parts which, in 253 
addition to increasing the cost, was also inconvenient:  254 
 255 
 “It was more annoying, basically I had to buy a new tank because the coils didn’t fit in the 256 
same tank anymore, or like stuff was discontinued.”(InterviewNo.27)  257 
 258 
One participant, however, did comment that, although inconvenient, the restrictions on tanks 259 
had improved functionality and safety: 260 
 261 
The pro is that they don’t leak, and that is a real plus and no vaper wants a leaky tank and 262 
they never bothered before about making sure they were all leak proof, so that’s a good 263 
thing. (InterviewNo.31) 264 
 265 
The reduction in tank size to 2ml and refill bottles to 10ml was an unpopular change amongst 266 
the participants who reported having to refill the tank more frequently and carry several 267 
smaller refill bottles around with them. In addition, they reported that it made the vaping 268 
process more difficult as everything is now smaller.  269 
 270 
 “TPD restrictions are well meaning but misguided. It is completely pointless to restrict the 271 
size of bottles and tanks, in fact it may even add to the problem. If you need to constantly 272 
keep topping up a small tank, you need to carry bottles of liquid, and restricting bottle size 273 
does not make people carry less liquid.”(SurveyNo.49) 274 
 275 
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Some participants commented that reduced tank size could discourage smokers to switch due 276 
to the added inconvenience:  277 
  278 
“Convenience is a big factor in helping smokers transition to vaping so I think it's a big 279 
shame. Specifically: It's a [pain] to keep filling up your tank every few hours.” (SurveyNo.88) 280 
 281 
In addition to finding the smaller bottles inconvenient, many participants were uncomfortable 282 
with the extra plastic waste that was being generated as a result of using far more plastic 283 
bottles of e-liquid than before the legislation:  284 
 285 
“I'm more concerned about the environmental impact of many, many more tiny plastic bottles 286 
being produced. This is a backward step for the environment.” (SurveyNo.78) 287 
 288 
Behavioural Reactions 289 
Many participants did not discuss any behavioural reactions, because they were not aware of 290 
the TPD and/or they were using compliant products pre-regulation. Reported reactions 291 
included participants who had pre-empted the TPD and began home mixing e-liquid enabling 292 
them to create higher nicotine strength liquid and/or keep the price of e-liquid low rather than 293 
buying expensive 10ml bottles. They had bought the nicotine base before the legislation came 294 
into force:  295 
 296 
 “I stocked up on high strength nicotine solution (72mg/ml) before the TPD came into force - 297 
I have about 4 years supply left.”(SurveyNo.24) 298 
 299 
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Participants reported benefitting from retailers stocking nicotine shots which could be added 300 
to larger bottles of 0mg e-liquids: 301 
 302 
 “The bottle size doesn't stop people purchasing the same amount of e-juice, and of course 303 
there are ways (legal ways) around the legislation which suppliers provide, such as shake 304 
and mix type purchasing (purchasing nicotine shots to add to a larger flavour bottle).” 305 
(SurveyNo.2) 306 
 307 
Many participants had bought non-compliant products from the black market via countries 308 
where the regulations did not apply, with China, USA, and the Isle of Man being the most 309 
commonly mentioned countries:  310 
 311 
 “If you order it from outside the UK, they will send out the bigger tank glasses without a 312 
second thought.”(InterviewNo.36) 313 
 314 
 “Since I continue to use 24mg/ml, which is prohibited under the TPD, I have no alternative 315 
but to source products from the black market.”(SurveyNo.136) 316 
 317 
These participants believed that this was the only way they could purchase higher strength 318 
nicotine and larger tanks that contributed to the vaping set up which worked well for them. A 319 
couple acknowledged the impact on domestic business and commented that they would have 320 
preferred to support local shops if the products were available: 321 
 322 
“Small businesses in the UK are throttled and for little need.” (SurveyNo.139) 323 
 324 
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Some also had concerns that purchasing in this way put their safety at further risk because 325 
they did not trust the quality of black market foreign products: 326 
 327 
“Making my own liquid is more of a problem. Getting nicotine concentrate isn't as easy, 328 
sourcing it nowadays means getting what could be dodgy stuff[...] I still have some nicotine 329 
base in the freezer. When that runs out, I'll have a problem, but I'll just have to use the black 330 
market and risk getting "bad" ingredients.” (SurveyNo.111) 331 
 332 
 333 
Future Reflections 334 
Many vapers, although pleased with the ingredients’ listings/restrictions as outlined above, 335 
wanted further regulation on the content of liquids and safety of devices. They felt that this 336 
would give them much needed reassurance that the products they were using were as safe as 337 
possible: 338 
 339 
“I think that’s a good thing[…] It’s alluding to a degree of quality control, you know, the 340 
actual chemicals that they do put in the liquid, but I think they could have probably gone a bit 341 
further and you know just made that any chemicals or flavouring, they know are safe or not 342 
known to be carcinogenic”(InterviewNo.2) 343 
 344 
Some participants who wanted further regulation for product safety were not aware that e-345 
liquid ingredients had already been regulated as part of the TPD legislation: 346 
 347 
 “I’d be happy to see more regulations. I don’t know how much has been done in this area 348 
already, on the liquids, on the additives and the alcohols and the sort of diacetyl and things 349 
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like this, the extra things that could be harmful in it. I mean I know there is a lot of choice out 350 
there now […] I don’t know how strict they are in what chemicals go into the product […] 351 
And I actually don’t know if that is being regulated enough yet.” (InterviewNo.8) 352 
 353 
In contrast to inclusion of ingredients lists, the vast majority of participants thought that the 354 
inclusion of the ‘contains nicotine’ warning label, including hardware and 0mg liquids, was 355 
nonsensical and confusing: 356 
 357 
“Mandatory warning labels on mods or empty atomizers saying they contain nicotine are, in 358 
my opinion, plain ridiculous and serve no purpose” (SurveyNo.114) 359 
 360 
“I think it’s misinformation in terms of all the kit have got to have it marked “this product 361 
contains nicotine” which as we well know a lot of them don’t.” (InterviewNo.6) 362 
 363 
Many participants felt that the warning label may deter people switching from smoking, 364 
although no participant reported that the warning label making them think twice about 365 
vaping. A couple proposed that warning labels should instead focus on communicating 366 
reduced harm messages to smokers on tobacco cigarette packets in an attempt to nudge them 367 
into switching to less harmful vaping. 368 
 369 
“[Tobacco packaging] is all standardized in terms of the colour and you know big health 370 
warnings on there and pictures of you know people with their throats falling out and stuff! 371 
[…] I think if they, rather than it all just being you know pictures of, all the horrible things 372 
they put on there[…] is to actually maybe actually have some information about alternatives 373 
like vaping, you know, vaping is 95% safer. I think those kind of nudging ways of 374 
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encouraging people, you know as well as the health warnings would be helpful.” 375 
(InterviewNo.2) 376 
 377 
DISCUSSION 378 
To the best of our knowledge, this is the first study of consumers’ views and reported 379 
experiences of the EU-TPD. Mixed reported experiences of TPD were illuminated, ranging 380 
from no impact or awareness, to illegal purchasing of non-compliant products.  Aspects of 381 
the TPD that participants agreed with, irrespective of whether or not they were previously 382 
aware of the regulations, were greater manufacturing regulations and full ingredients 383 
labelling. Participants wanted reassurance about the safety of the products they were using 384 
and would welcome further regulations addressing this, mirroring the UK Government’s 385 
commitment to fund research into product toxicity (30). A previous UK survey of smokers, 386 
ex-smokers, and vapers, showed that awareness for most of the TPD regulations was less 387 
than 10% (26). It can be inferred that, like many participants in this study, the vast majority 388 
of e-cigarette users are not familiar with the legislation. It is reassuring that this participant 389 
group did not knowingly experience any negative impacts. However, these participants 390 
perceived vaping products to be currently unregulated and, in some cases, wanted regulations 391 
that were already in place. It may be helpful to raise awareness of the TPD among 392 
consumers, as smokers may be put off switching if they think products are not subject to any 393 
regulation or control.  394 
 395 
It is encouraging that no participants commented that they had relapsed as a direct result of 396 
the restrictions, as most had adapted to the changes or were already using compliant products, 397 
but some participants had decided to purchase illegal products, such as nicotine strength over 398 
20mg/ml.  For some participants, the nicotine strength liquid they originally used to quit 399 
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smoking was no longer available. However, most tobacco quitters using e-cigarettes today 400 
may not need to use illegal strengths, because technology has advanced alongside the TPD 401 
implementation, meaning that devices are more powerful and effective at delivering nicotine 402 
and that lower strength e-liquids can be satisfying (41). It is worth noting though that many 403 
new users lack vaping experience and may initially use less sophisticated devices which may 404 
require higher strength liquid to be effective or satisfying (42, 43). In addition, using 405 
advanced devices with high power alongside lower nicotine results in compensatory puffing 406 
causing vapers to use more e-liquid which can increase exposure to potential toxicants and 407 
carcinogens (44, 45). The nicotine strength limit, however, has been suggested as a possible 408 
reason for the UK having comparatively lower rates of youth vaping compared to North 409 
America (46), which, if evidenced, should be carefully considered when reviewing the 410 
legislation. Stricter marketing restrictions have also been suggested as a possible reason for 411 
comparatively lower rates of youth vaping.  Interestingly, advertising was not discussed by 412 
any of the participants, indicating established e-cigarette users may not be expressively 413 
concerned with that part of the legislation.  414 
 415 
Many participants in this study reported experiencing an increase in the price of vaping 416 
products, less product choice, and added inconvenience. Factors in the success of using e-417 
cigarettes to stay stopped from smoking are not limited to e-liquid nicotine strength, but also 418 
include having a satisfying functioning vaping set-up which is affordable and convenient 419 
(31). Therefore, although not demonstrated in this study of mostly exclusive e-cigarette users, 420 
it is possible that the TPD regulations may have had the unintended consequence of making it 421 
more difficult for some smokers to quit using an e-cigarette, and warrants further 422 
investigation.  These potential barriers to switching may be further compounded by TPD 423 
warning labels which have been found to deter smokers from using e-cigarettes (47), 424 
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although similar messages have been shown to have the potential to deter never smokers 425 
from trying e-cigarettes (48, 49).  Harm reduction messages comparing e-cigarettes to 426 
tobacco, such as “Use of this product is much less harmful than smoking” (50), have been 427 
explored in relation to e-cigarette packaging and advertising (47, 50, 51), but future research 428 
could focus on their inclusion on tobacco packaging as suggested by participants in this study 429 
as a way of nudging smokers to switch to less harmful vaping.  430 
 431 
Paradoxically, the TPD restrictions prompted some vapers to buy much higher concentrates 432 
and amounts of nicotine than they would have otherwise, through stocking up on large 433 
quantities of nicotine before the TPD came into force or purchasing nicotine shots to add to 434 
larger bottles of 0mg/ml liquid. This behaviour, also noted elsewhere (27, 28), contradicts 435 
one of the main objectives of the legislation, potentially posing greater safety risks, e.g. 436 
accidental poisoning by swallowing. In addition, the TPD restrictions had prompted some 437 
participants to buy unregulated illegal products. Black market products may pose risks to 438 
consumers (35) and safety was a significant worry for participants who perceived foreign 439 
vaping products to be inferior and more hazardous than EU produced products. Although 440 
likely to be used by only a minority of e-cigarette users in the UK, these results indicate that 441 
there is a black market offering products which are no longer legally available, such as 442 
nicotine strengths above 20ml/mg, eliquid bottles larger than 10ml, and prohibited 443 
components.  444 
 445 
Limitations 446 
Although the sample can be considered large for a qualitative study, these findings may not 447 
be generalisable to the wider e-cigarette user population, and, therefore, whilst evidencing 448 
experiences of the TPD (in line with the study’s aim), they cannot give an indication of how 449 
 20 
 
widespread the issues discussed are. Indeed, the sample had disproportionate representation 450 
from white males, andthe sample consisted mostly of consumers who wereexclusive e-451 
cigarette users who reported being impacted by the TPD. In contrast, it is likely that the vast 452 
majority of UK e-cigarette users will have not knowingly been affected by the changes. 453 
However, it is still important to listen to the views of those consumers that have been affected 454 
in order to improve future policy. For example, policy makers are unlikely to want anyone 455 
turning to the black market ideally, and ways of limiting this should be considered. In 456 
addition, i is also important in reviewing policy to ask consumers what they value in 457 
legislation affecting them, irrespective of their awareness of current legislation; fortunately, 458 
despite over representation of some groups, the large sample enabled a range of perspectives 459 
to be reported, including women who were less likely to report awareness or impacts of the 460 
TPD. It would be helpful though to gain more views from minority groups, and those that had 461 
relapsed to smoking, to explore the full range of possible views and experiences of the 462 
regulations. 463 
 464 
Another limitation was that the vast majority of respondents were from the UK; it is not clear 465 
whether the TPD was experienced similarly in other EU countries, although the same themes 466 
were identified in data from the small group of participants not residing in the UK. As 467 
expected, data generated via verbal interview were generally richer than data generated via 468 
the survey, although the same themes were identified through triangulation. It was beyond the 469 
scope of the project to obtain the views of smokers, never smokers, and young people, 470 
although it would be helpful to explore whether the TPD protects these groups as intended    471 
 472 
Conclusions 473 
 21 
 
This research indicates that awareness of the TPD was not universal and restrictions do not 474 
appear to have influenced participants’ smoking relapse behaviour. Consumers valued 475 
regulatory changes that supported informed decision making (e.g. ingredients lists) and safety 476 
(e.g. regulation of e-liquid contents). They responded negatively to changes that caused 477 
inconvenience and plastic waste (e.g. smaller e-liquid refill bottles and tanks/cartridges). This 478 
research shows that the TPD legislation has prompted some consumers potentially to put their 479 
safety at risk by purchasing noncompliant products from the black market. The cost of these 480 
impacts needs to be balanced against the potential benefit of deterring non-smokers and 481 
children from vaping, and more research is needed to ascertain to what extent the legislation 482 
has achieved this benefit. The implications of our analysis suggest that, from a consumer 483 
perspective, future e-cigarette regulation should not further restrict liquid/tank volumes and 484 
nicotine concentration, but should focus on ensuring product safety, particularly around 485 
ingredients used in e-liquids. Public health bodies, Stop Smoking Services, and healthcare 486 
professionals should consider raising awareness of the regulations to smokers to offer 487 
reassurance about vaping products and e-liquid ingredients, for example by signposting to 488 
educational materials (e.g. 36). Vape retailers also have a responsibility to communicate to 489 
customers how aspects of the regulations are designed to protect consumers.        490 
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Survey: 694 
 695 
Do you live in an EU country (including the UK)? 696 
o Yes  (1)  697 
o No  (2)  698 
 699 
 700 
Display This Question: 701 
If Do you live in an EU country (including the UK)? = Yes 702 
 703 
The Tobacco Products Directive (TPD) is an EU Directive which restricts liquid bottle sizes to 704 
10ml, tank sizes to 2ml, and nicotine strength to 20mg. Liquid has to have its ingredients 705 
listed on the label, and vaping products including hardware have to have a warning label on 706 
them stating they contain nicotine.     How has the legislation affected you? 707 
(advantages/disadvantages, change in price, availability or effectiveness, changed you 708 
vaping behaviour? E.g. started home mixing, buy on the black market). Please comment in 709 
the box below:    710 
________________________________________________________________ 711 
________________________________________________________________ 712 
________________________________________________________________ 713 
________________________________________________________________ 714 
________________________________________________________________ 715 
 716 
 717 
Interview: 718 
 719 
‘Last time we spoke to you was just before the Tobacco Products Directive legislation came 720 
in last May. Are you aware of the legislation?’ Give brief description of legislation: ‘It 721 
restricted the bottle sizes you could buy to 10ml, tank sizes to 2ml, and nicotine strength to 722 
20mg. It meant that liquid had to have its ingredients listed on the label and  that vaping 723 
products, including hardware, had to have a warning label on them stating they contained 724 
nicotine. 725 
‘What are your thoughts on this legislation?’ ‘Advantages/disadvantages?’ 726 
‘Has this legislation affected you at all?’ ‘How?’ ‘Have you noticed a change to the 727 
price, availability, or effectiveness of products?’ ‘Have you changed your purchasing 728 
behaviour as a result?’ (Prompt for home mixing, online purchasing, black or second 729 
hand market, modifying).   730 
